Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2009;29:1916-1922
Published online before print September 3, 2009, doi: 10.1161/ATVBAHA.109.194803
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
29/11/1916    most recent
ATVBAHA.109.194803v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Lidington, D.
Right arrow Articles by Bolz, S.-S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lidington, D.
Right arrow Articles by Bolz, S.-S.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2009;29:1916.)
© 2009 American Heart Association, Inc.


Cell Biology/Signaling

The Phosphorylation Motif at Serine 225 Governs the Localization and Function of Sphingosine Kinase 1 in Resistance Arteries

Darcy Lidington; Bernhard Friedrich Peter; Anja Meissner; Jeffrey T. Kroetsch; Stuart M. Pitson; Ulrich Pohl; Steffen-Sebastian Bolz

From the Department of Physiology (D.L., A.M., J.K., S.-S.B.) and the Heart & Stroke/Richard Lewar Centre of Excellence in Cardiovascular Research (S.-S.B.), University of Toronto, Canada; the Institute of Physiology (B.F.P.), Walter-Brendel-Centre of Experimental Medicine (U.P.), Ludwig-Maximilians-University, Munich, Germany; and the Hanson Institute, Human Immunology (S.M.P.), Institute of Medical and Veterinary Science, Adelaide, Australia.

Correspondence to Steffen-Sebastian Bolz, MD, PhD, Department of Physiology University of Toronto, Medical Sciences Building, room 3326, 1 King’s College Circle, Toronto, Ontario, Canada, M5S 1A8. E-mail sts.bolz{at}utoronto.ca

Objective— The purpose of this study was to characterize a phosphorylation motif at serine 225 as a molecular switch that regulates the pressure-dependent activation of sphingosine kinase 1 (Sk1) in resistance artery smooth muscle cells.

Methods and Results— In isolated hamster gracilis muscle resistance arteries, pressure-dependent activation/translocation of Sk1 by ERK1/2 was critically dependent on its serine 225 phosphorylation site. Specifically, expression of Sk1S225A reduced resting and myogenic tone, resting Ca2+, pressure-induced Ca2+ elevations, and Ca2+ sensitivity. The lack of function of the Sk1S225A mutant could not be entirely overcome by forced localization to the plasma membrane via a myristoylation/palmitylation motif; the membrane anchor also significantly inhibited the function of the wild-type Sk1 enzyme. In both cases, Ca2+ sensitivity and myogenic tone were attenuated, whereas Ca2+ handling was normalized/enhanced. These discrete effects are consistent with cell surface receptor-mediated effects (Ca2+ sensitivity) and intracellular effects of S1P (Ca2+ handling). Accordingly, S1P2 receptor inhibition (1µmol/L JTE013) attenuated myogenic tone without effect on Ca2+.

Conclusions— Translocation and precise subcellular positioning of Sk1 is essential for full Sk1 function; and two distinct S1P pools, proposed to be intra- and extracellular, contribute to the maintenance of vascular tone.

We demonstrate in hamster resistance arteries that the serine 225 phosphorylation site on sphingosine kinase 1 (Sk1) is a molecular switch for its regulatory function in smooth muscle cells. It is critical for pressure-dependent Sk1 activation/translocation and cannot be bypassed by an artificial membrane anchor.


Key Words: myogenic vasoconstriction • signal transduction • transfection • ERK1/2 • sphingosine-1-phosphate